Protagenic Therapeutics, Inc.
PTIX
$3.55
$0.4916.01%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 739.80K | 287.90K | 453.30K | 277.60K | 200.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.64M | 652.10K | 1.67M | 1.74M | 1.21M |
| Operating Income | -1.64M | -652.10K | -1.67M | -1.74M | -1.21M |
| Income Before Tax | -1.55M | -640.80K | -1.61M | -1.72M | -1.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.55M | -640.80K | -1.61M | -1.72M | -1.68M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.55M | -640.80K | -1.61M | -1.72M | -1.68M |
| EBIT | -1.64M | -652.10K | -1.67M | -1.74M | -1.21M |
| EBITDA | -1.63M | -639.50K | -1.65M | -1.73M | -1.19M |
| EPS Basic | -3.51 | -1.98 | -5.06 | -5.44 | -5.34 |
| Normalized Basic EPS | -2.31 | -1.24 | -3.27 | -3.40 | -2.33 |
| EPS Diluted | -3.51 | -1.98 | -5.06 | -5.46 | -5.34 |
| Normalized Diluted EPS | -2.31 | -1.24 | -3.27 | -3.40 | -2.33 |
| Average Basic Shares Outstanding | 442.20K | 323.50K | 317.40K | 316.80K | 313.90K |
| Average Diluted Shares Outstanding | 442.20K | 323.50K | 317.40K | 316.80K | 313.90K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |